Previous Article | Next Article 
Applied and Environmental Microbiology, July 2001, p. 2927-2931, Vol. 67, No. 7
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.7.2927-2931.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Assessing the Risk of Primary Amoebic
Meningoencephalitis from Swimming in the Presence of Environmental
Naegleria fowleri
Pierre-André
Cabanes,1,*
France
Wallet,1
Emmanuelle
Pringuez,2 and
Pierre
Pernin3
Service des Études
Médicales1 and Division Recherche
et Développement,2
Électricité de France, 78401 Chatou Cedex, and
Laboratoire de Biologie Cellulaire EA 1655, Faculté de
Pharmacie, 69373 Lyon Cedex 08,3 France
Received 3 November 2000/Accepted 15 April 2001
 |
ABSTRACT |
Free-living Naegleria fowleri amoebae cause primary
amoebic meningoencephalitis (PAM). Because of the apparent
conflict between their ubiquity and the rarity of cases observed, we
sought to develop a model characterizing the risk of PAM after
swimming as a function of the concentration of N. fowleri.
The probability of death from PAM as a function of the number of
amoebae inhaled is modeled according to results obtained from animals
infected with amoeba strains. The calculation of the probability of
inhaling one or more amoebae while swimming is based on a double
hypothesis: that the distribution of amoebae in the water follows a
Poisson distribution and that the mean quantity of water inhaled while swimming is 10 ml. The risk of PAM for a given concentration of amoebae
is then obtained by summing the following products: the probability of
inhaling n amoebae × the probability of PAM
associated with inhaling these n amoebae. We chose the
lognormal model to assess the risk of PAM because it yielded the
best analysis of the studentized residuals. Nonetheless, the levels of
risk thereby obtained cannot be applied to humans without correction,
because they are substantially greater than those indicated by
available epidemiologic data. The curve was thus adjusted by a factor
calculated with the least-squares method. This provides the PAM risk in
humans as a function of the N. fowleri concentration in the
river. For example, the risk is 8.5 × 10
8 at a
concentration of 10 N. fowleri amoebae per liter.
 |
INTRODUCTION |
Free-living amoebae are ubiquitous
protozoa that have been isolated from most regions of the world. One
species, Naegleria fowleri, is potentially pathogenic in
humans, causing fatal primary amoebic meningoencephalitis (PAM)
(5). It grows preferentially in warm water (25 to 44°C)
and has been isolated from both natural and artificial sources
(2, 12-14, 16, 20, 43, 44).
The first case of PAM was described in 1965 (23). Human
infection by N. fowleri occurs by the nasal route, after
contact between water containing the amoebae and the nasal mucosa.
After possible local multiplication, amoebae cross the nasal mucosa and
the cribriform plate of the ethmoid bone and invade the brain, where
they cause hemorrhage, inflammation, and extensive necrosis. Death
usually occurs 10 to 14 days after exposure (35). More than 180 cases have now been reported throughout the world.
Most of the cases have been reported in the United States, Australia,
and the Czech Republic (respectively, 81, 19, and 18 cases). They most
often involve children in good health or young adults (i) who had been
swimming in heated pools or thermal waters (Czech Republic, Belgium, or
New Zealand [7, 8, 29, 30, 36]) or in ponds, lakes, or
rivers (North America [1, 10, 17, 19, 21]), or (ii) who
were infected as a result of using domestic water colonized by these
amoebae (Australia [4, 5]).
There are few available data from humans on which we can base a
quantitative assessment of the risk of PAM associated with swimming or
other recreational activity carried out in water containing N. fowleri. Until now, the only estimate, which is based on data from
Florida (43), reported a risk of 7 cases per billion
swimming episodes in water for which no precise N. fowleri
concentration has been measured (but up to 40 N. fowleri
amoebae/liter).
These data are insufficient for a precise estimate of the PAM risk to
swimmers as a function of the N. fowleri concentration in
the water. In the field of chemical carcinogenesis, when no human data
are available, the risks associated with exposure to low doses are
usually assessed by modeling experimental results from animal exposure
to high doses and then extrapolating these results first to low doses
and then to humans. This procedure assumes that there is no threshold
below which exposure is not associated with an increase in risk. In
microbiology, the same procedure was developed by Haas
(26) in 1983 but has had only a limited development since
then (24, 25, 27, 28, 40), probably because of
methodological problems associated with work on microorganisms,
compared with chemical or physical agents.
The goal of this study is to assess the risk of PAM for swimmers
potentially exposed to N. fowleri.
 |
MATERIALS AND METHODS |
The risk for humans of contracting PAM while swimming in fresh
water results from the occurrence of both of the two following independent events: first, the risk of exposure to n N. fowleri amoebae when swimming in water with a concentration,
c, of N. fowleri, and, second, the risk of
developing PAM after inhaling a number n of N. fowleri amoebae.
Animal experiments.
To model this risk, we used a mouse
model and carried out experimental inoculation of mice with nine
different strains of N. fowleri isolated from five different
thermally polluted watercourses in France. The concentration of
N. fowleri in water was determined by incubating replicate
samples at 44°C on non-nutrient agar plates spread with
Escherichia coli according to the following procedure: filtration of 10 × 100 ml, 30 × 10 ml and direct deposit of
20 × 1 ml, 20 × 0.1 ml; the results were expressed as the
most probable number (MPN) per liter after recording the number of
positive plates for each replicate. After isolation and identification by isoenzyme typing (37), the N. fowleri
strains were axenized on serum-caseine-glucose-yeast extract medium at
37°C. For inoculation, the amoebae were recovered by gentle agitation
followed by 800 × g centrifugation of the culture
medium. After decanting the supernatant, the amoebae were resuspended
and the concentration of the N. fowleri suspension was
determined by at least three separate cell counts with a Thoma
hemocytometer. The nasal instillation was performed on groups of at
least 10 1-month-old Swiss OF1 female mice, which were first
anesthetized by intraperitoneal injection of a mixture of ketamine,
diazepam, and atropine; 17 µl of the amoebic suspension was deposited
intranasally in mice lying in the dorsal decubitus position. The
initial inoculum ranged from 4.8 × 104 to 1.9 × 103 amoebae per mouse, depending on the strain tested. For
two strains (D98.2.1.h10. and SL98.2.1.f17.),
we carried out successive 10-fold dilutions of the initial suspension
in order to establish dose-response curves for groups of 20 mice.
The animals were observed daily, for a period of at least 21 days, in
order to monitor them for the appearance of clinical signs
characteristic of PAM.
We also integrated into these results previous published data from
three other experiments with mice (3, 31, 44). We used
these experimental data to model the probability of death from PAM as a
function of the number of amoebae inhaled.
Modeling the risk of PAM from animal data.
Evidence that no
single model is specifically adapted to microbiological experimentation
can be found in the fact that so many models have been proposed
(26). To determine which was most appropriate to these
observations, we tested five that are frequently used for similar
studies: the fractional (derived from a logistic model), lognormal,
Weibull, Beta, and uniform distribution models. Two estimators were
used to determine the models' parameters: maximum likelihood and least
squares. We studied the validity of each model with a
Kolmogorov-Smirnov test and an analysis of the studentized residuals.
Calculation of risk associated with one swimming episode.
In
assuming that distribution of amoebae in the water follows a Poisson
distribution, the probability of inhaling n amoebae (Pinh) as a function of their concentration in
the water is as follows:
where c is the concentration of amoebae per
liter of water, v is the volume of water inhaled, expressed
in liters, and n is the number of amoebae inhaled.
We assumed that the mean quantity of water inhaled by the nose during a
swimming episode is 10 ml. This volume corresponds to the amount
prescribed for nasal irrigation (5 ml per nostril), which is
representative of a prolonged swim with the head underwater.
The risk r of death from PAM during one exposure to water
containing N. fowleri is then
where pdeath is the probability
of death from PAM when n amoebae are inhaled, calculated by
the preceding modeling process from the animal experimental data.
This first step produced a risk curve with no correction factor for
extrapolation to humans. We then compared the data with the global risk
estimate that Wellings based on human epidemiologic data. We estimated
the curve for the maximum risk of human death from PAM by adjusting the
first curve to the risk observed in Florida (43), choosing
the lowest concentration observed (set at 1 N. fowleri per
liter, the detection limit of the MPN methods [44]). The
curve corresponding to the minimum risk was obtained by adjusting the
first curve to the risk observed in Florida, choosing the highest
concentration (40 N. fowleri amoebae/liter). The adjustment
factors of the curve were calculated by the least-squares method.
 |
RESULTS |
Inoculation of mice with strains of N. fowleri isolated
from watercourses in France provided results similar to those of
previously published animal experiments. A significant relation between
mouse mortality and infecting dose was observed (Table
1). Additionally, the mean time to death
increased with decreasing amoeba doses. Our experiments were performed
with 10 to 20 mice per dose, more than are usually used in this kind of
experiment (compare with 5 mice per dose [3, 44] and 10 mice per dose [31]). This is not, however, a large
number from a statistical viewpoint, and thus the percentages obtained
vary substantially, as shown by the wide 95% confidence interval of
mortality in the sample population, estimated from charts
(41) and based on the observed frequencies of PAM in the
mice (Fig. 1).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Probability of PAM in mice (with 95% confidence
interval [CI]) as a function of amoebic dose instilled.
|
|
All the experimental results were used for the modeling. The best
results were obtained with the maximum-likelihood method in the
fractional and lognormal models. The Weibull, Beta, and uniform models
were not considered valid by the Kolmogorov-Smirnov test. Figure
2 reports for both the retained models
the risk of PAM in mice as a function of the number of amoebae inhaled.
Because these results were similar, we used the lognormal model, which gave the best coefficient of correlation (0.96) and the best analysis of residuals.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Modeling of the probability of PAM in mice as a function
of amoebic number with two mathematical models.
|
|
The risk of PAM during a human swimming episode was calculated as
described above. Figure 3 shows the risk
of PAM calculated as a function of the concentration of amoebae in the
water. This first curve contains no correction factor for the
extrapolation from mice to humans.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Modeling the risk of PAM, as a function of amoebic
concentration in water without any correction factor for extrapolation
from mice to humans.
|
|
The values of the maximum and minimum extrapolation factors were found
to be 20 and 88, respectively. A realistic estimation of the PAM risk
as a function of the N. fowleri concentration should be
located between these two curves, which correspond to the minimum and
maximum estimation of risk in humans (Fig.
4).
In the process of risk assessment, the precautionary principle is
routinely applied by selecting the highest risk estimates in cases of
uncertainty. Accordingly, when we choose the "maximum" model, the
risk of PAM associated with swimming once in water containing a
concentration of 10 N. fowleri amoebae per liter is 8.5 × 10
8. For 100 N. fowleri per liter, it
reaches 2.5 × 10
6, and for 1,000 N. fowleri
amoebae per liter, it reaches 2.6 × 10
4.
 |
DISCUSSION |
This article reports for the first time a quantitative estimate of
the risk of PAM associated with swimming, as a function of the N. fowleri concentration in the water. This estimate required that we
make several assumptions, clearly stated, about the values of the
parameters involved in calculating this risk.
The first curve, which was based on animal data, was adjusted according
to the published estimate based on human epidemiologic data
(43). Two principal reasons justify this.
First, several articles lead us to conclude that humans are more
resistant to MAP than mice are. For example, no case of PAM associated
with N. australiensis or N. italica has so far
been described among humans, although these species are pathogenic for
mice (15). Moreover, while many studies (6, 9, 18, 34, 39) have shown the presence of anti-N. fowleri
antibodies in humans, these have not been found in laboratory animals;
this may explain the greater resistance among humans. Antibodies are important because they may immobilize the amoebae and slow their migration. Slower migration might make effective treatment possible if
the infection is diagnosed in time. Antibodies may also enhance complement lysis of amoebae (42).
Second, the data collected in southern Australia about infection
through a public water system confirm our estimate: 10 PAM cases (of
the 19 reported for the entire continent) and a number of exposures of
the order of 3 billion (1.5 million inhabitants, for the region of
Adelaide, over a 15-year period, taking at least 100 baths or showers,
with water inhalation, per year). The concentrations measured varied
from 1 to 400 amoebae per liter.
We have bounded the risk interval observed in Florida by minimum and
maximum N. fowleri concentrations. Although Wellings found
that many samples of large volumes of water were negative for this
amoeba, we chose a lower limit of 1 amoeba per liter, because it
corresponds to the threshold detection limit for the MPN methods
routinely used. Furthermore, the exposures, or bathing episodes, are
essentially linked to the warmest periods, that is, to the season when
amoeba concentrations are highest. Finally, for low concentrations, the
yields of detection methods are low (38), so that
concentrations that do not take the method's yield into account are underestimated.
When we consider the construction of the model itself, we note that the
risks calculated for the low concentrations are based primarily on the
estimated risk associated with the inhalation of a single amoeba. Can
one N. fowleri alone cause PAM? Ferrante (22)
considers that significant doses of amoebae must be inhaled to cause
the disease. The inhalation of sediment particles that serve as a
support for the attachment and growth of amoebae may fulfill this
condition. The formation of such microaggregates, made up of several
dozen or even several hundred amoebae, is observed on floating
particles even in axenic cultures and can occur fortuitously under
natural conditions, especially in the absence of current. The
inhalation of these particles, after they have become suspended in the
water, may be associated with particular sporting activities (diving,
underwater swimming, etc.) and might thus directly provide the minimum
infectious dose that Ferrante considers to exist. By supposing that a
single amoeba can cause the illness, the model tends to overestimate
the risk, as indeed the procedures for risk assessment call for in the
presence of uncertainty. We must nonetheless bear in mind that the
model was then adjusted on the basis of human data from Florida, and
that the Australian data, based on slightly different exposure
processes, yield a risk estimate concordant with ours.
Finally, the risk of death from PAM has been modeled from animal data.
Although the three studies previously published yielded similar
results, they were based on a very small number of mice (5 to 10),
which resulted in a wide confidence interval. Moreover, the strains of
N. fowleri used for these nasal instillations had been
passed previously through the brains of mice, a treatment known to
increase the virulence of this amoeba (33). In swimming episodes, the public is exposed to environmental or wild amoebae, which
may be less pathogenic. Conversely, it has been established that the
virulence of trophozoites diminishes with time, as subculturing takes
place in axenic cultures (11). For this reason, we tried to follow a procedure similar to the natural circumstances of infection
to assess the virulence of the strains from different French water
sources; that is, mice were exposed to amoebae as soon as they were
axenized, after isolation and identification. Under these conditions,
the results we obtained with groups of 20 mice per dose are completely
equivalent to those of previous studies, but their 95% confidence
interval is narrower (Table 1 and Fig. 1). The study by John and
Nussbaum (32), who exposed mice by making them swim in
water containing different concentrations of N. fowleri for
varying durations, confirms our results.
Conclusion.
The extrapolation of animal observations at high
doses to low doses by modeling is an essential chain in the procedure
of health risk assessment, now commonly used in the domain of cancer. Microbiology reasons more often in terms of a minimal infecting dose,
but it is not certain that this concept has any reality for many
microorganisms. Thus, if we accept that one N. fowleri can,
after local multiplication, cause PAM, this type of extrapolation is justified.
In addition, the decision to adjust the animal experimental curve to
make it correspond to the available human data is clearly appropriate,
for the initial animals results were much greater than the apparent
risk to humans. From the point of view of risk management, it appears
appropriate to choose to model the maximum human risk.
Based upon this quantitative risk assessment, the French health
authorities have set a maximum level of 100 N. fowleri
amoebae per liter, not to be exceeded in watercourses where human
exposure is possible.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Service des
Études Médicales, EDF-GDF, 22-28 rue Joubert, 75009 Paris, France. Phone: 33 1 55 31 46 02. Fax: 33 1 55 31 46 20. E-mail:
pierre-andre.cabanes{at}edfgdf.fr.
 |
REFERENCES |
| 1.
|
Barnett, N. D. P.,
A. M. Kaplan,
R. J. Hopkin,
M. A. Saubolle, and M. F. Rudinsky.
1996.
Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review.
Pediatr. Neurol.
15:230-234[CrossRef][Medline].
|
| 2.
|
Brown, T. J.,
R. T. Cursons,
E. A. Keys,
M. Marks, and M. Miles.
1983.
The occurrence and distribution of pathogenic free-living amoebae in thermal areas of North Island of New Zealand.
N.Z. J. Mar. Freshwater Res.
17:59-69.
|
| 3.
|
Carter, R. F.
1970.
Description of a Naegleria sp. isolated from two cases of primary amoebic meningo-encephalitis and of the experimental pathological changes induced by it.
J. Pathol.
100:217-244[CrossRef][Medline].
|
| 4.
|
Carter, R. F.
1972.
Primary amoebic meningoencephalitis.
Trans. R. Soc. Trop. Med. Hyg.
66:193-213[CrossRef][Medline].
|
| 5.
|
Carter, R. F.
1968.
Primary amoebic meningoencephalitis: clinical pathological and epidemiological features of six fatal cases.
J. Pathol. Bacteriol.
96:1-25[CrossRef][Medline].
|
| 6.
|
Cerva, L.
1989.
Acanthamoeba culbertsoni and Naegleria fowleri: occurrence of antibodies in man.
J. Hyg. Epidemiol. Microbiol. Immunol.
33:99-103[Medline].
|
| 7.
|
Cerva, L.
1968.
Amoebic meningoencephalitis: sixteen fatalities.
Science
160(823):92[Abstract/Free Full Text].
|
| 8.
|
Cerva, L.
1971.
Studies of limax amoebae in a swimming pool.
Hydrobiologia
38:141-161.
|
| 9.
|
Cursons, R. T.,
T. J. Brown,
E. A. Keys,
K. M. Moriarty, and D. Till.
1980.
Immunity to pathogenic free-living amoebae: role of humoral antibody.
Infect. Immun.
29:401-407[Abstract/Free Full Text].
|
| 10.
|
Darby, C. P.,
S. E. Conradi,
T. W. Holbrook, and C. Chatellier.
1979.
Primary amebic meningoencephalitis.
Am. J. Dis. Child.
133:1025-1027[Abstract].
|
| 11.
|
De Jonckheere, J. F.
1979.
Differences in virulence of Naegleria fowleri.
Pathologie Biologie
27:453-458.
|
| 12.
|
De Jonckheere, J. F.
1979.
Occurrence of Naegleria and Acanthamoeba in aquaria.
Appl. Environ. Microbiol.
38:590-593[Abstract/Free Full Text].
|
| 13.
|
De Jonckheere, J. F.
1981.
Pathogenic and nonpathogenic Acanthamoeba sp. in thermally polluted discharges and surface waters.
J. Protozool.
28:56-59[Medline].
|
| 14.
|
De Jonckheere, J. F.
1979.
Studies on pathogenic free-living amoebae in swimming pools.
Bull. Inst. Pasteur
77:385-392.
|
| 15.
|
De Jonckheere, J. F.,
M. Aerts, and A. J. Martinez.
1983.
Naegleria australiensis: experimental meningoencephalitis in mice.
Trans. R. Soc. Trop. Med. Hyg.
77:712-716[CrossRef][Medline].
|
| 16.
|
De Jonckheere, J. F., and H. Van De Voorde.
1977.
The distribution of N. fowleri in man-made thermal waters.
Am. J. Trop. Med. Hyg.
76:10-15.
|
| 17.
|
DeNapoli, T. S.,
J. R. Robinson,
J. Y. Rutman, and M. M. Rhodes.
1996.
Primary amoebic meningoencephalitis after swimming in the Rio Grande.
Tex. Med.
92(10):59-63[Medline].
|
| 18.
|
Dubray, B. L.,
W. E. Wilhelm, and B. R. Jennings.
1987.
Serology of Naegleria fowleri and Naegleria lovaniensis in a hospital survey.
J. Protozool.
34:322-327[Medline].
|
| 19.
|
Duma, R. J.
1978.
The epidemiology of naturally acquired human, waterborne meningoencephalitis due to thermophilic, pathogenic Naegleria, p. 107-116.
In
R. Gerhold (ed.), Proceedings of Symposium of Microbiology of Power Plant Thermal Effluents. University of Iowa Press, Iowa City.
|
| 20.
|
Duma, R. J.
1981.
Study of pathogenic free-living amebas in fresh-water lakes in Virginia. U.S.
Environmental Protection Agency, Washington, D.C.
|
| 21.
|
Duma, R. J.,
H. W. Ferrell,
E. C. Nelson, and M. M. Jones.
1969.
Primary amoebic meningoencephalitis.
N. Engl. J. Med.
281:1315-1323.
|
| 22.
|
Ferrante, A.
1991.
Free-living amoebae: pathogenicity and immunity.
Parasite Immunol.
13:31-47[Medline].
|
| 23.
|
Fowler, M., and R. F. Carter.
1965.
Acute pyogenic meningitis probably due to Acanthamoeba sp. A preliminary report.
BMJ
2(5464):740-742.
|
| 24.
|
Gerba, C. P.,
J. B. Rose,
C. N. Haas, and K. D. Crabtree.
1996.
Waterborne rotavirus: a risk assessment.
Water Res.
30:2929-2940[CrossRef].
|
| 25.
|
Gibson, C., III,
C. Haas, and J. Rose.
1998.
Risk assessment of waterborne protozoa: current status and future trends.
Parasitology
117:S205-212.
|
| 26.
|
Haas, C. N.
1983.
Estimation of risk due to low doses of microorganisms: a comparison of alternative methodologies.
Am. J. Epidemiol.
118:573-582[Abstract/Free Full Text].
|
| 27.
|
Haas, C. N.,
C. S. Crockett,
J. B. Rose,
C. P. Gerba, and A. M. Fazil.
1996.
Assessing the risk posed by oocysts in drinking water.
J. Am. Water Works Assoc.
88:131-136.
|
| 28.
|
Haas, C. N.,
J. B. Rose,
C. Gerba, and S. Regli.
1993.
Risk assessment of virus in drinking water.
Risk Anal.
13:545-552[CrossRef][Medline].
|
| 29.
|
Hermanne, J.
1974.
Primary amoebic meningo-encephalitis. Clinical aspects.
Ann. Soc. Belg. Med. Trop.
54:287-295[Medline].
|
| 30.
|
Jadin, J. B.
1974.
Primary amoebic meningo-encephalitis and the pathogenicity of water-borne amoebas.
Bull. Acad. R. Med. Belg.
126:439-466.
|
| 31.
|
John, D. T., and K. L. Hoppe.
1990.
Susceptibility of wild mammals to infection with Naegleria fowleri.
J. Parasitol.
76:865-868[CrossRef][Medline].
|
| 32.
|
John, D. T., and S. L. Nussbaum.
1983.
Naegleria fowleri infection acquired by mice through swimming in amoebae-contaminated water.
J. Parasitol.
69(5):871-874[CrossRef][Medline].
|
| 33.
|
Marciano-Cabral, F.
1988.
Biology of Naegleria spp.
Microbiol. Rev.
52:114-133[Free Full Text].
|
| 34.
|
Marciano-Cabral, F.,
M. L. Cline, and S. G. Bradley.
1987.
Specificity of antibodies from human sera for Naegleria species.
J. Clin. Microbiol.
25:692-697[Abstract/Free Full Text].
|
| 35.
|
Martinez, A. J., and G. S. Visvesvara.
1997.
Free-living, amphizoic and opportunistic amebas.
Brain Pathol.
7:538-598.
|
| 36.
|
Nicoll, A. M.
1973.
Fatal primary amoebic meningoencephalitis.
N. Z. Med. J.
78(496):108-112[Medline].
|
| 37.
|
Pernin, P., and G. Grelaud.
1989.
Application of isoenzymatic typing to the identification of nonaxenic strains of Naegleria (Protozoa, Rhizopoda).
Parasitol. Res.
75:595-598[CrossRef][Medline].
|
| 38.
|
Pernin, P.,
M. Pélandakis,
Y. Rouby,
A. Faure, and F. Siclet.
1998.
Comparative recoveries of Naegleria fowleri amobae from seeded river water by filtration and centrifugation.
Appl. Environ. Microbiol.
64:955-959[Abstract/Free Full Text].
|
| 39.
|
Reilly, M. F.,
F. Marciano-Cabral,
D. W. Bradley, and S. G. Bradley.
1983.
Agglutination of Naegleria fowleri and Naegleria gruberi by antibodies in human serum.
J. Clin. Microbiol.
17:576-581[Abstract/Free Full Text].
|
| 40.
|
Rose, J. B., and C. P. Gerba.
1991.
Use of risk assessment for development of microbial standards.
Water Sci. Technol.
24:29-34.
|
| 41.
|
Saporta, G.
1990.
Probabilités, analyses des données et statistiques.
Technip, France.
|
| 42.
|
Toney, D. M., and F. Marciano-Cabral.
1994.
Membrane vesiculation of Naegleria fowleri amoebae as a mechanism for resisting complement damage.
J. Immunol.
152:2952-2959[Abstract].
|
| 43.
|
Wellings, F. M.,
P. T. Amuso,
S. L. Chang, and A. L. Lewis.
1977.
Isolation and identification of pathogenic Naegleria from Florida lakes.
Appl. Environ. Microbiol.
34:661-667[Abstract/Free Full Text].
|
| 44.
|
Wellings, F. M.,
P. T. Amuso,
A. I. Lewis,
M. J. Farmelo,
D. J. Moody, and C. L. Osikowicz.
1979.
Pathogenic Naegleria: distribution in nature. U.S.
Environmental Protection Agency, Cincinnati, Ohio.
|
Applied and Environmental Microbiology, July 2001, p. 2927-2931, Vol. 67, No. 7
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.7.2927-2931.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Maciver, S. K.
(2007). The threat from Balamuthia mandrillaris. J Med Microbiol
56: 1-3
[Full Text]
-
Robinson, B. S., Monis, P. T., Dobson, P. J.
(2006). Rapid, Sensitive, and Discriminating Identification of Naegleria spp. by Real-Time PCR and Melting-Curve Analysis. Appl. Environ. Microbiol.
72: 5857-5863
[Abstract]
[Full Text]